|
Server : Apache/2.4.62 System : FreeBSD fbsdweb2.web.rcn.net 14.1-RELEASE FreeBSD 14.1-RELEASE releng/14.1-n267679-10e31f0946d8 GENERIC amd64 User : www ( 80) PHP Version : 8.3.8 Disable Function : NONE Directory : /domains/bluerae/clients/mipi/prototype3/about/ |
Upload File : |
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
<meta name="description" content="Molecular Insight is focused on critical diagnostic and therapeutic needs of the prostate cancer patient." />
<meta name="keywords" content="prostate cancer, prostate cancer detection, prostate cancer treatment, small-molecule, radiotherapy, metastatic prostate cancer" />
<title>Molecular Insight: Executive Management</title>
<link href="../stylesmenu.css" rel="stylesheet" type="text/css" />
<link href="../styles.css" rel="stylesheet" type="text/css" />
</head>
<body>
<div id="container">
<!-- LEFT CONTAINER - CONTAINS ALL ELEMENTS ON LEFT HALF OF PAGE, EACH POSITIONED ABSOLTELY -->
<div id="leftcontainer">
<div id="logo"><a href="../index.html"><img src="../images/logo.gif" width="241" height="315" alt="Molecult Insight Home" /></a></div>
<div id="mininav"><a href="../about/contact.html">CONTACT US</a> :: <a href="../search/sitemap.html">SITEMAP</a> :: <a href="../search/index.html">SEARCH</a></div>
<div id="pagemenu">
<p class="currentsection">About Us</p>
<ul>
<li><a href="index.html">Overview</a></li>
<li><a href="executive.html" class="current">Executive Management</a></li>
<li><a href="board.html">Board of Directors</a></li>
<li><a href="scientific.html">Scientific Advisory Board</a></li>
<li><a href="careers.html">Careers</a></li>
<li><a href="MolecularInsight_FactSheet.pdf">Fact Sheet (PDF)</a></li>
<li><a href="video.html">Corporate Video</a></li>
<li><a href="licensing.html">Licensing</a></li>
</ul>
</div>
<div id="photolarge"><img src="images/p_about.jpg" width="241" height="342" alt=" " /></div>
<div id="photosmall"><img src="images/p2_about.jpg" width="140" height="181" alt=" " /></div>
<div id="contactinfo">
<p class="address">Molecular Insight Pharmaceuticals, Inc.<br />
<a href="http://maps.google.com/maps?q=160+Second+Street,+Cambridge,+MA+02142&oe=utf-8&client=firefox-a&hnear=160+2nd+St,+Cambridge,+Massachusetts+02142&gl=us&t=m&z=16" target="_blank" class="softlink">160 Second Street, Cambridge, MA 02142</a><br />
617.492.5554 tel :: 617.492.5664 fax<br />
<a href="email:[email protected]">[email protected]</a><br />
</p>
</div>
</div><!--close left container-->
<!-- MAIN CONTENT - includes main menu at top -->
<div id="maincontent" >
<div id="mainmenu">
<ul>
<!--<li style="width: 400px;"> </li>-->
<li><a href="../about/index.html" class="current">About Us<span class="separator">::</span></a>
<ul>
<li><a href="../about/executive.html">Executive Management</a></li>
<li><a href="../about/board.html">Board of Directors</a></li>
<li><a href="../about/scientific.html">Scientific Advisory Board</a></li>
<li><a href="../about/careers.html">Careers</a></li>
<li><a href="../about/MolecularInsight_FactSheet.pdf">Fact Sheet (PDF)</a></li>
<li><a href="../about/video.html">Corporate Video</a></li>
<li><a href="../about/licensing.html">Licensing</a></li><img src="../images/menu_bottom.png" width="168" height="8" alt=" " class="menubottom" />
</ul>
</li>
<li><a href="../molecular/index.html">Molecular Medicine<span class="separator">::</span></a>
<ul>
<li><a href="../molecular/mip.html">Molecular Imaging <br />Pharmaceuticals</a></li>
<li><a href="../molecular/tr.html">Targeted Radiotherapeutics</a></li>
<li><a href="../molecular/pt.html">Proprietary Technologies</a></li><img src="../images/menu_bottom.png" width="168" height="8" alt=" " class="menubottom" />
</ul></li>
<li><a href="../pipeline/index.html">Pipeline<span class="separator">::</span></a>
<ul>
<li><a href="../pipeline/prostate.html">Prostate Cancer</a></li>
<li><a href="../pipeline/diagnostic.html">Diagnostic</a></li>
<li><a href="../pipeline/therapeutic.html">Therapeutic</a></li>
<li><a href="../pipeline/discovery.html">Discovery</a></li>
<li><a href="../pipeline/presentations.html">Presentations & Publications</a></li><img src="../images/menu_bottom.png" width="168" height="8" alt=" " class="menubottom" />
</ul></li>
<li><a href="../intheclinic/index.html">In the Clinic<span class="separator">::</span></a></li>
<li><a href="../media/index.html">Media Room</a>
<ul>
<li><a href="../media/releases.html">Press Releases</a></li>
<li><a href="../media/clips.html">Press Clips</a></li>
<li><a href="../media/interviews.html">Interviews</a></li><img src="../images/menu_bottom.png" width="168" height="8" alt=" " class="menubottom" />
</ul>
</li>
</ul>
</div>
<h1 class="pagehead">Executive Management</h1>
<p class="introtext">Molecular Insight is led by a highly experienced and proven management team. Each member has a strong track record in high-performance organizations that have created significant and sustainable value. </p>
<p>The drug development process can be complex and Molecular Insight’s management team offers deep expertise in all aspects of the process to drive products toward commercialization. </p>
<h2><strong>John W. Babich, Ph.D.</strong></h2>
<h3>President and Chief Scientific Officer </h3>
<p>John W. Babich, Ph.D., a founder of the company in 1997, serves as President and Chief Scientific Officer. He has been an active researcher in the field of molecular imaging and targeted radionuclide therapy for the past 25 years. Prior to joining the Company, he was Assistant Professor of Radiology at Harvard Medical School and Staff Radiopharmaceutical Chemist at Massachusetts General Hospital (MGH), Boston, Massachusetts. Prior to joining MGH, Dr. Babich was Principal Scientist and Head of the Radiopharmaceutical Section at the Institute of Cancer Research in England. Dr. Babich's current research efforts focus on molecular imaging in oncology, neurology, and cardiovascular disease. His previous research experience includes detection of breast and colorectal cancer using monoclonal antibodies, pharmacological and <em>in vivo</em> biological studies of novel small molecules for targeted therapy of neuroblastoma, the use of peptide-based molecular imaging agents for the detection of infection and cancer, and the use of positron emission tomography for the study of drug interactions in humans. He has published more than 100 research articles in a variety of peer-reviewed journals, as well as several book chapters and invited reviews. He is inventor or co-inventor of numerous issued and pending patents licensed to or property of the Company. He is also co-inventor of a cardiac imaging product currently marketed by Mallinckrodt-TycoHealthcare, Inc. as Ultra-Tag. Dr. Babich served as President of the Society of Nuclear Medicine's Radiopharmaceutical Science Council. Dr. Babich received a B.S. degree in pharmaceutical sciences from St. John’s University, an M.S. from University of Southern California, and a Ph.D. from the University of London. </p>
<h2><strong>Wendy Graham-Coco </strong> </h2>
<h3>Vice President, Portfolio Strategy and Manufacturing </h3>
<p>In December 2009, Wendy Graham-Coco was named Vice President of Portfolio Strategy and Manufacturing, a role in which she directs the collection, assimilation and management of data to best understand patient need, the physician perspective and ultimately the market uptake of the Company’s product portfolio. Her Portfolio Strategy responsibilities include providing strategic input on business development activities, including partnering initiatives. In her capacity as head of manufacturing, Ms. Graham-Coco coordinates all manufacturing and supply chain activities, both for the Company and for its partners. She continues to lead Molecular Insight’s program management team. Ms. Graham-Coco has served as Vice President since January of 2008. She has more than 20 years of research experience, including 16 years in discovery research, of which seven were in academic drug discovery at the Massachusetts General Hospital in Boston. She has experience managing various phases of drug development, including preclinical development, early clinical development and manufacturing. Prior to her tenure as Vice President at Molecular Insight, Ms. Graham-Coco served in various roles in Program Management, Operations and Business Development. She earned a B.A. in biology, Pre-Med at Boston University and an M.B.A. from Simmons Graduate School of Management. </p>
<h2><strong>John L. Joyal, Ph.D</strong> </h2>
<h3>Vice President of Discovery Research </h3>
<p>John L. Joyal, Ph.D. has served as our Vice President of Discovery Research since January of 2008. He joined Molecular Insight as Director of Biology in 2005. He has over 20 years of oncology basic research and drug discovery experience with expertise in cell and molecular biology particularly in the areas of receptor biology, signal transduction pathways, and assay development. Prior to joining Molecular Insight, Dr. Joyal was Director of Discovery Research at Phylogix Pharmaceuticals where he led a team evaluating the biology and mechanism of action of protein therapeutics for oncology supportive care. From 1997 to 2004, he held several positions at Praecis Pharmaceuticals including Director of Cell Biology, where he initiated or contributed to the establishment of numerous research projects focusing on the discovery of novel therapeutics for the treatment of cancer, inflammation, infectious disease, and neurological disorders. From 1993 to 1997, Dr. Joyal did his post-doctoral training at Harvard Medical School/Brigham and Women’s Hospital examining novel interactions between the calcium sensor, calmodulin, and proteins involved in breast carcinogenesis and growth factor signaling. He received his Ph.D. in biology from Tufts University studying mitochondrial physiology.</a> </p>
<h2><strong>Kevin J. Lloyd</strong></a> </h2>
<h3>Vice President, Clinical and Development Operations</h3>
<p>Kevin Lloyd joined Molecular Insight in May 2012 as Vice President, Clinical and Development Operations. He has over 19 years of experience in Clinical Development, working at both large and small biopharmaceutical companies, an academic medical center, and a large Contract Research Organization (CRO) in the greater Boston area. Prior to joining Molecular Insight, Mr. Lloyd was Executive Director of Clinical Operations at ZIOPHARM Oncology, where he oversaw operations for the DNA Therapeutics franchise from ZIOPHARM's exclusive channel partnership with Intrexon Corporation. From 2006 to 2011, Mr. Lloyd was instrumental in establishing and heading the Clinical Business Operations group at Millennium Pharmaceuticals, which included the creation and optimization of centralized clinical contract, budget, and training functions in support of Millennium's Medical Division. From 1998 to 2006, he held positions of progressive responsibility in Clinical Operations and Development at Millennium, ImmunoGen and Biogen, Inc. Previously, he worked in clinical roles at PAREXEL International Corporation and Tufts New England Medical Center. In addition to his extensive background in Clinical Development and Operations in all phases of drug development, Mr. Lloyd has strong experience in a variety of oncology therapeutic areas. He received a B.A. from the University of Vermont. </p>
<h2><strong>James A. Wachholz </strong> </h2>
<h3>Vice President, Regulatory Affairs and Quality Assurance </h3>
<p>James A. Wachholz has served as Vice President, Regulatory Affairs and Quality Assurance since May 2005. He has more than 20 years of experience in regulatory affairs and product development at biotechnology and pharmaceutical companies. From 2003 to May 2005, he worked at Accentia Biopharmaceuticals, where he served as Chief Regulatory Officer. From 1998 to 2003 Mr. Wachholz worked at Sepracor Inc., where he served as the Executive Director of Regulatory Affairs. Previously, Mr. Wachholz held regulatory and compliance positions at Hybridon, Inc., Searle Pharmaceuticals and Baxter International. Mr. Wachholz received a B.S. in biochemistry from Northern Illinois University and an M.B.A. from DePaul University. </p>
<p> </p>
<!-- FOOTER - contained within main content div -->
<div id="footer">
<p>Copyright © 2012 Molecular Insight. All Rights Reserved. :: <a href="../privacy.html">Privacy Policy</a> :: <a href="../terms.html">Terms of Use</a></p>
</div>
</div>
</div><!--close container-->
</body>
</html>